HOME Top Market Reports Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: June 2015
Report Code: PH 3475

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global animal vaccines market is poised to reach $7,197.9 Million by 2020 from $5,507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020.

In this report, the global animal vaccines market is segmented on the basis of products, diseases, technologies, and regions.

Based on product type, the veterinary vaccine market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines (including vaccines for deer, elephants, camels, bats, and rabbits). Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans, and the growing pet population.

On the basis of diseases, the animal vaccines market is classified into companion animal diseases, poultry diseases, porcine diseases, equine diseases, and aquaculture diseases. The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment accounted for the highest growth veterinary vaccine technologies market in 2014.

Growth of the veterinary vaccines market is propelled by growing prevalence of animal diseases; rising incidences of zoonotic diseases in humans; increasing investments by various government agencies, animal associations, and leading players; continuous innovations and introduction of new veterinary vaccines. Furthermore, technological innovations like DNA vaccines, growing awareness of animal health in emerging economies, increasing investment opportunities in emerging and immature markets are also the factors driving the market growth. However, rising maintenance costs for storage of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, persistent economic slowdown are key factors limiting the growth of this market.

Key players operating in the veterinary vaccines market are Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Boehringer Ingelheim (Germany), Ceva (France), Elcano Animal Health (USA), Heska Co. (U.S.), Merck Animal Health (U.S.), Merial (Sanofi) (U.S.), Virbac (France), and Zoetis (Pfizer) (U.S.).

Scope of the Report

  • This report covers the global and regional market for animal vaccines, on the basis of products, animal diseases, and technologies
  • This study does not include country-level data and the market size by volume
  • This report does not provide data tables for the technology market at the global level

Particular

Scope

Region

  • North America
  • Europe
  • Asia
  • RoW

Historical Years

2013

Base Year

2014

Projected Year

2015

Forecast Period

2015–2020

Revenue Currency

USD ($)

Market Segmentation

This research report categorizes the veterinary vaccines market on the basis of products, diseases, technologies, and regions.

Veterinary Vaccines Market, by Product

  • Companion Animal Vaccines
  • Livestock Vaccines
  • Poultry Vaccines
  • Porcine Vaccines
  • Equine Vaccines
  • Aquaculture Vaccines
  • Other Animal Vaccines

Veterinary Vaccines Market, by Disease

  • Livestock Diseases
    • Bovine Vaccines, by Disease
      • Foot-and-mouth Disease
      • Bovine Viral Diarrhea
      • Bovine Clostridial Diseases
      • Brucellosis
      • Infectious Bovine Rhinotracheitis
      • Others
    • Small Ruminant Animal Vaccines, by Disease
      • Small ruminant Clostridial Diseases
      • Scabby Mouth Infection
      • Pneumonia & Septicemia
      • Pox Diseases
      • Ovine Johne's Disease
      • Other
  • Porcine Diseases
    • Porcine Parvovirus
    • Porcine Reproductive Respiratory Syndrome (PRRS)
    • Porcine Circovirus II
    • Swine Influenza
    • Swine Pneumonia
    • Auzeszky's Disease
    • Others
  • Poultry diseases
    • Infectious Bronchitis
    • Gumboro Disease
    • Avian Influenza
    • Coccidiosis
    • Marek’s Disease
    • Newcastle Disease
    • Mycoplasma
    • Others
  • Companion Animal Diseases
    • Canine Vaccines, by Disease
      • Canine Rabies
      • Canine Distemper
      • Canine Parvovirus
      • Infectious Canine Hepatitis
      • Others
    • Feline Vaccines, by Disease
      • Feline Rabies
      • Feline Panleukopenia
      • Feline Viral Rhinotracheitis
      • Feline Leukemia
      • Others
  • Equine Diseases
    • Equine Encephalomyelitis
    • Strangles
    • Tetanus
    • Equine Influenza
    • Equine Rhinopneumonitis
    • Others
  • Aquaculture Diseases
    • Vibriosis
    • Pasteurellosis
    • Furunculosis
    • Others

Veterinary Vaccines Market, by Technology

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Recombinant Vaccines
  • DNA Vaccines

Veterinary Vaccines Market, by Region

  • North America
  • Europe
  • Asia
    • China
    • India
    • Thailand
  • RoW (Rest of the World)
    • Brazil

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions for the Study

3 Executive Summary (Page No. - 30)

4 Premium Insights (Page No. - 37)
    4.1 Veterinary Vaccines Market to Grow at A Steady Rate
    4.2 Veterinary Vaccines Market, By Product
    4.1 Veterinary Vaccines Market, By Region
    4.2 Veterinary Vaccines Market, By Technology
    4.3 Lifecycle Analysis, By Region

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Diseases in Animals
                    5.2.1.2 Increasing Incidence of Zoonotic Diseases
                    5.2.1.3 Increasing Investments By Various Government Agencies, Animal Associations, and Leading Players
                    5.2.1.4 Introduction of New Types of Vaccines
           5.2.2 Restraints
                    5.2.2.1 Rising Maintenance Costs for Storage of Vaccines
                    5.2.2.2 Increasing Adoption of Vegetarian Food Across Major Economies
           5.2.3 Opportunities
                    5.2.3.1 Technological Innovations Such as DNA Vaccines
                    5.2.3.2 Growing Awareness of Animal Health in Emerging Economies

6 Veterinary Vaccines Market, By Product (Page No. - 47)
    6.1 Introduction

7 Veterinary Vaccines Market, By Disease (Page No. - 50)
    7.1 Introduction
    7.2 Porcine Vaccines, By Disease
    7.3 Porcine Diseases: Overview
    7.4 Poultry Vaccines, By Disease
    7.5 Poultry Diseases: Overview
    7.6 Companion Animal Vaccines, By Disease
    7.7 Canine Vaccines
    7.8 Canine Diseases: Overview
    7.9 Feline Vaccines
    7.10 Feline Diseases: Overview
    7.11 Livestock Vaccines, By Disease
           7.11.1 Bovine Vaccines
    7.12 Bovine Diseases: Overview
           7.12.1 Small Ruminant Vaccines, By Disease
    7.13 Samll Ruminant Diseases: Overview
    7.14 Equine Vaccines, By Disease
    7.15 Equine Diseases: Overview
    7.16 Aquaculture Vaccines, By Disease
    7.17 Aquaculture Diseases: Overview

8 Veterinary Vaccines Market, By Technology (Page No. - 68)
    8.1 Introduction 
    8.2 Live Attenuated Vaccines (LAV)
    8.3 Inactivated Vaccines
    8.4 Toxoid Vaccines
    8.5 Recombinant Vaccines
    8.6 Conjugate Vaccines
    8.7 Subunit Vaccines
    8.8 DNA Vaccines

9 Veterinary Vaccines Market, By Region (Page No. - 81)
    9.1Introduction 
    9.2 Europe
    9.3 North America
    9.4 Asia
    9.5 China
           9.5.1 Thailand
                    9.5.1.1 Regulatory Landscape for Veterinary Vaccines in Thailand
    9.6 India
    9.7 Rest of the World (RoW)
    9.8 Brazil

10 Competitive Landscape (Page No. - 157)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Veterinary Vaccines Market, Major Developments, By Product (2013–2015)
             10.3.1 Recent Developments By Market Players (2013–2015)
                        10.3.1.1 Zoetis (Pfizer)
                        10.3.1.2 Merck Animal Health
                        10.3.1.3 Boehringer Ingelheim
                        10.3.1.4 Ceva Animal Health
     10.4 Competitive Situation and Trends
             10.4.1 New Product Launches
             10.4.2 Agreements, Partnerships, and Collaborations
             10.4.3 Acquisitions
             10.4.4 Expansion
             10.4.5 Other Developments

11 Company Profiles (Page No. - 168)
     11.1 1.1 Introduction
     11.2 Bayer Healthcare
             11.2.1 Business Overview
             11.2.2 Product Portfolio
             11.2.3 Recent Developments
     11.3 Bioniche Animal Health
             11.3.1 Business Overview
             11.3.2 Product Portfolio
             11.3.3 Recent Developments
     11.4 Boehringer Ingelheim
             11.4.1 Business Overview
             11.4.2 Product Portfolio
             11.4.3 Recent Developments
             11.4.4 MnM View
     11.5 Ceva Animal Health
             11.5.1 Business Overview
             11.5.2 Product Portfolio
             11.5.3 Recent Developments
     11.6 Elanco Animal Health (Eli Lilly)
             11.6.1 Business Overview
             11.6.2 Product Portfolio
             11.6.3 Recent Developments
             11.6.4 MnM View
     11.7 Heska Corporation
             11.7.1 Business Overview
             11.7.2 Product Portfolio
             11.7.3 Recent Developments
     11.8 Merck Animal Healthcare
             11.8.1 Business Overview
             11.8.2 Product Portfolio
             11.8.3 Recent Developments
             11.8.4 MnM View
     11.9 Merial Inc. (SANOFI)
             11.9.1 Business Overview
             11.9.2 Product Portfolio
             11.9.3 Recent Developments
             11.9.4 MnM View
     11.10 Virbac
             11.10.1 Business Overview
             11.10.2 Product Portfolio
             11.10.3 Recent Developments
     11.11 Zoetis
             11.11.1 Business Overview
             11.11.2 Product Portfolio
             11.11.3 Recent Developments
             11.11.4 MnM View

12 Appendix (Page No. - 193)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports


List of Tables (124 Tables)

Table 1 Growing Incidence of Zoonotic Diseases to Drive the Animal Vaccines Market
Table 2 High Maintenance and Storage Cost of Vaccines to Restrain Market Growth
Table 3 Technological Advancements Likely to Boost the Veterinary Vaccines Market
Table 4 Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 5 Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 6 Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 7 Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 8 Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 9 Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 10 Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 11 Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 12 Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 13 Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 14 Live Attenuated Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 15 Inactivated Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 16 Toxoid Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 17 Recombinant Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 18 Conjugate Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 19 Subunit Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 20 DNA Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 21 Animal Vaccines Market Size, By Region, 2013–2020 ($Million)
Table 22 Europe: Veterinary Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 23 Europe: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 24 Europe: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 25 Europe: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 26 Europe: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 27 Europe: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 28 Europe: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 29 Europe: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 30 Europe: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 31 Europe: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 32 Europe: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 33 Europe: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 34 Europe: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 35 Europe: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 36 Europe: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 37 Europe: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 38 Europe: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 39 North America: Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 40 North America: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 41 North America: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 42 North America: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 43 North America: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 44 North America: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 45 North America: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 46 North America: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 47 North America: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 48 North America: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 49 North America: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 50 North America: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 51 North America: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 52 North America: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 53 North America: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 54 North America: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 55 North America: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 56 China: Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 57 China: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 58 China: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 59 China: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 60 China: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 61 China: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 62 China: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 63 China: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 64 China: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 65 China: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 66 China: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 67 China: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 68 China: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 69 China: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 70 China: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 71 China: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 72 China: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 73 Thailand: Veterinary Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 74 Thailand: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 75 Thailand: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 76 Thailand: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 77 Thailand: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 78 Thailand: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 79 Thailand: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 80 Thailand: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 81 Thailand: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 82 Thailand: Livestock Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 83 Thailand: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 84 Thailand: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 85 Thailand: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 86 India: Animal Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 87 India: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 88 India: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 89 India: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 90 India: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 91 India: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 92 India: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 93 India: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 94 India: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 95 India: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 96 India: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 97 India: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 98 India: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 99 India: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 100 India: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 101 India: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 102 India: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 103 Brazil: Veterinary Vaccines Market Size, By Product, 2013–2020 ($Million)
Table 104 Brazil: Porcine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 105 Brazil: Porcine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 106 Brazil: Livestock Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 107 Brazil: Bovine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 108 Brazil: Small Ruminant Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 109 Brazil: Livestock Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 110 Brazil: Poultry Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 111 Brazil: Poultry Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 112 Brazil: Companion Animal Vaccines Market Size, By Category, 2013–2020 ($Million)
Table 113 Brazil: Canine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 114 Brazil: Feline Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 115 Brazil: Companion Animal Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 116 Brazil: Equine Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 117 Brazil: Equine Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 118 Brazil: Aquaculture Vaccines Market Size, By Disease, 2013–2020 ($Million)
Table 119 Brazil: Aquaculture Vaccines Market Size, By Technology, 2013–2020 ($Million)
Table 120 New Product Launches, 2013–2015
Table 121 Agreements, Partnerships, and Collaborations, 2013–2015
Table 122 Acquisitions, 2013-2015
Table 123 Expansions, 2013-2015
Table 124 Other Developments, 2012–2015
 
 
List of Figures (65 Figures)
 
Figure 1 Research Design: Veterinary Vaccines Market
Figure 2 Market Size Estimation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Animal Vaccines Market Snapshot (2015 vs. 2020): Companion Animal Vaccines Segment to Grow at the Highest CAGR
Figure 6 Live Attenuated Vaccines Segment is Expected to Dominate the Animal Vaccines Technologies Market in 2015
Figure 7 Asia-Pacific Market to Witness the Highest Growth During the Forecast Period
Figure 8 Figure 1 Attractive Market Opportunities
Figure 9 Porcine Vaccines Segment Accounted for the Largest Share in 2014
Figure 10 Asia is Expected to Be the Fastest-Growing Region During the Forecast Period
Figure 11 Live Attenuated Vaccines Technology Segment is Expected to Dominate the Animal Vaccines Market During the Forecast Period
Figure 12 Increasing Incidence of Zoonotic Diseases to Boost Market Growth
Figure 13 Porcine Vaccines Commanded Largest Share of the Veterinary Vaccines Market in 2014
Figure 14 Porcine Circovirus Segment Projected to Grow at Highest Rate in Porcine Vaccines Market, By 2020
Figure 15 Infectious Bronchitis Segment Dominated the Poultry Vaccines Market in 2014
Figure 16 Canine Distemper Segment Projected to Grow at Highest Rate in Canine Vaccines Market By 2020
Figure 17 Feline Rabies Segment Dominated Feline Vaccines Market in 2014
Figure 18 BVD Segment Projected to Grow at Highest Rate in Bovine Vaccines Market By 2020
Figure 19 Clostridial Diseases Segment Dominated the Small Ruminant Vaccines Market in 2014
Figure 20 Equine Rhinopneumonitis Segment Projected to Grow at Highest Rate in Equine Vaccines Market By 2020
Figure 21 Vibriosis Segment Dominated the Aquaculture  Vaccines Market in 2014
Figure 22 Live Attenuated Vaccines Dominated the Global Animal Vaccines Market in 2014
Figure 23 Poultry Vaccines Dominated the Live Attenuated Vaccines Market in 2014
Figure 24 Companion Animal Vaccines to Witness the Highest Growth Rate in the Inactivated Vaccines Market By 2020
Figure 25 Livestock Vaccines Dominated the Toxoid Vaccines Market in 2014
Figure 26 Porcine Vaccines to Grow at the Highest Rate in the Recombinant Vaccines Market By 2020
Figure 27 Porcine Vaccines Dominated the Conjugate Vaccines Market in 2014
Figure 28 Livestock Vaccines to Grow at the Highest Rate in the Subunit Vaccines Market By 2020
Figure 29 Porcine Vaccines Dominated the DNA Vaccines Market in 2014
Figure 30 Geographic Snapshot Asia to Witness the Highest Growth in the Forecast Period
Figure 31 Asia, an Attractive Destination for All Product Categories
Figure 32 Europe Will Continue to Lead the Global Veterinary Vaccines Market in the Forecast Period
Figure 33 The Demand for Animal Vaccines Will Be Driven By the Growing Production of Pig Meat in the Forecast Period
Figure 34 The Porcine Vaccines Segment Accounted for the Largest Share of the European Veterinary Vaccines Market, By Product
Figure 35 Recombinant Vaccines Technology Will Be the Fastest-Growing Segmenting European Veterinary Vaccines Market in the Forecast Period
Figure 36 The Inactivated Vaccines Technology Segment Accounted for the Largest Share of the European Companion Animal Vaccines Market
Figure 37 The Live Attenuated Vaccines Technology Segment Accounted for the Largest Share of the North America Livestock Vaccines Market
Figure 38 Asia Market Snapshot: the Demand for Veterinary Vaccines Will Be Driven By Increasing Incidences of Zoonotic Diseases
Figure 39 The Livestock Vaccines Segment Accounted for the Largest Share of the Veterinary Vaccines Market in China
Figure 40 Conjugate Vaccines Technology Will Be the Fastest-Growing Segment for Asian Animal Vaccines Market  in the Forecast Period
Figure 41 The Porcine Vaccines Segment Accounted for the Largest Share of the Thailand Veterinary Vaccines Market
Figure 42 Recombinant Vaccine Technology Segment to Witness the Highest Growth  Thailand Veterinary Vaccines Market in the Forecast Period
Figure 43 The Livestock Vaccines Segment Accounted for the Largest Share of the Animal Vaccines Market in India
Figure 44 Conjugate Vaccines Technology Segment to Witness the Highest Growth in Livestock Vaccines Market the Forecast Period
Figure 45 The Poultry Vaccines Segment Accounted for the Largest Share of the Animal Vaccines Market in Brazil
Figure 46 Inactivated Vaccines Technology Segment to Grow at the Highest CAGR in Poultry Vaccines Market in the Forecast Period
Figure 47 Companies Adopted New Product Launches and Licenses as Their Key Growth Strategy (2013-2015)
Figure 48 Global Animal Vaccines Market Share, By Key Player, 2014
Figure 49 Animal Vaccines Market, Major Developments (2013–2015)
Figure 50 Zoetis (Pfizer) Focused on Porcine Segment in Last Few Years (2013-2015)
Figure 51 Merck Concentrated on Livestock Segment (2013-2015)
Figure 52 Boehringer Ingelheim Mainly Concentrated on Equine Segment (2013-2015)
Figure 53 Ceva Released New Products for the Poultry Segment (2013 – 2015)
Figure 54 Battle for Market Share: New Product Launches Was the Key Growth Strategy
Figure 55 Geographic Revenue Mix of Top Five Market Players
Figure 56 Bayer Healthcare: Company Snapshot
Figure 57 Bioniche Animal Health: Company Snapshot
Figure 58 Boehringer Ingelheim: Company Snapshot
Figure 59 Ceva Animal Health: Company Snapshot
Figure 60 Elanco Animal Health: Company Snapshot
Figure 61 Heska Corporation: Company Snapshot
Figure 62 Merck Animal Healthcare: Company Snapshot
Figure 63 Merial Inc. (SANOFI): Company Snapshot
Figure 64 Virbac: Company Snapshot
Figure 65 Zoetis: Company Snapshot

The global animal vaccines market is poised to reach $7,197.9 Million by 2020 from $5,507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020.

Major factors fueling market growth are growing prevalence of animal diseases, increasing incidences of zoonotic diseases, rising investments by government bodies and associations, and launches of innovative products by companies. However, rising costs of storage and maintenance of vaccines, increasing adoption of vegetarian food in major economies owing to the high risk of obesity and other chronic disorders, persistent economic slowdown are expected to affect the growth of the veterinary vaccines market

The veterinary vaccine market, by product, is segmented into companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines (including vaccines for deer, elephants, camels, bats, rabbits). Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing awareness about vaccination, rising prevalence of zoonotic diseases, and increasing pets population.

The animal vaccines market, by technology, is categorized into inactivated vaccines, live attenuated vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines, recombinant vaccines, subunit vaccines.  live attenuated vaccines technology is the major technology of veterinary vaccines market.

Geographically, the veterinary vaccines market is dominated by Europe, followed by North America. The market in Asia is expected to grow at a highest CAGR during the forecast period.

Key players operating in the animal vaccines market are Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Boehringer Ingelheim (Germany), Elanco Animal Health (U.S.).

Veterinarty Vaccine Market Scenario, by Product, 2014

Animal Veterinary Vaccines Market

MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports